Pathogenesis of liver injury and hepatic fibrosis in Non-Alcoholic SteatoHepatitis, NASH
Pathogenesis of liver injury and hepatic fibrosis in Non-Alcoholic SteatoHepatitis, NASH
批准号:
nhmrc : 153899
负责人:
A/Pr Graham Robertson
金额:
$29.21万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2001
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2001-01-01 至 2003-12-31
中文摘要
非酒精性脂肪性肝炎(NASH)是富裕国家最常见的肝病形式。在澳大利亚,至少3%的人口和20%的肥胖者患有NASH。这种鲜为人知的疾病涵盖了一系列肝脏疾病-从相对良性的肝脏过度脂肪存在-到肝硬变和肝功能衰竭。这种肝损害模式实际上与酒精性肝炎相同,但NASH排除了饮酒。它通常与II型糖尿病、肥胖症和血脂紊乱有关。尽管脂肪肝本身被认为是无害的和可逆的,但少数患有这种轻度综合征的病例发展为更严重的NASH形式。该项目的一个目标是确定和描述在脂肪肝中引发损伤并导致肝细胞破坏的因素。作为对NASH患者最初的肝脏损伤的反应,肝脏中的细胞和免疫系统中的细胞会发生炎症反应。然而,这可能会放大最初的侮辱的影响,从而使肝脏更容易受到进一步的伤害。炎症反应由特定的肝脏和免疫细胞产生的关键信号分子控制。该项目的第二个目标是确定这些分子及其细胞来源,并确定它们是否使NASH的疾病过程永久化。肝脏损伤和随之而来的炎症反应的一个结果是,肝脏通过在类似于伤口愈合的过程中形成疤痕组织纤维来修复损伤。如果不加以控制,这个纤维化过程会导致肝硬变和严重的肝脏并发症。最终目的是对肝细胞损伤、炎症反应和纤维化之间的联系获得新的见解,最终将导致预防这种疾病的初始触发因素的治疗,并阻止NASH进展到更严重的纤维化阶段。
英文摘要
Nonalcoholic steatohepatitis (NASH) is the most common form of liver disease in affluent countries. In Australia at least 3% of the population and 20% of those with obesity have NASH. This poorly understood disease covers a spectrum of liver disorders - from relatively benign presence of excess fat in the liver - to cirrhosis and liver failure. This pattern of liver damage is virtually identical to alcoholic hepatitis, however alcohol consumption is excluded in NASH. It is often associated with type II diabetes , obesity and lipid disorders. Although fatty liver by itself is thought to be innocuous and reversible, a small number of cases with this mild syndrome progress to a more severe form of NASH. One aim of this project is to identify and characterise the factors which trigger injury in a fatty liver and lead to the destruction of liver cells. In response to the initial liver injury in NASH, cells in the liver and from the immune system mount an inflammatory reaction. However this may make the liver even more susceptible to further injury by amplifying the effect of the initial insult. The inflammatory response is controlled by key signalling molecules produced by specific liver and immune cells. The second aim of this project is to identify such molecules and their cellular source and to determine whether they perpetuate the disease processes of NASH. One outcome of liver injury and the consequent inflammatory reaction is that the liver repairs the damage by forming fibres of scar tissue in a process similar to wound healing. When unchecked this process of fibrosis leads to cirrhosis and the development of severe liver complications. The final aim is to gain new insights into the links between liver cell injury, the inflammatory response and fibrosis which will eventually lead to treatments to prevent the initial triggers of this disease and also to interrupt the progression of NASH to more serious fibrotic stage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nutrition and rehabilitation in advanced cancer patients
-
批准号:nhmrc : 446208
-
项目类别:Targeted Calls
-
资助金额:$15.07万
-
财政年份:2007
-
负责人:A/Pr Graham Robertson
-
依托单位:
Expression and regulation of human genes central to drug disposition in the brain
-
批准号:nhmrc : 352320
-
项目类别:NHMRC Project Grants
-
资助金额:$22.63万
-
财政年份:2005
-
负责人:A/Pr Graham Robertson
-
依托单位:
Repression of hepatic drug metabolism by solid tumours
-
批准号:nhmrc : 352419
-
项目类别:NHMRC Project Grants
-
资助金额:$33.61万
-
财政年份:2005
-
负责人:A/Pr Graham Robertson
-
依托单位:
Alternate signalling pathways regulating the human arachidonate epoxygenase CYP2J2 in response to stress stimuli
-
批准号:nhmrc : 301909
-
项目类别:NHMRC Project Grants
-
资助金额:$24.6万
-
财政年份:2004
-
负责人:A/Pr Graham Robertson
-
依托单位:
Molecular mechanisms of feed-forward regulation of bile acid detoxification and elimination in cholestasis
-
批准号:nhmrc : 302036
-
项目类别:NHMRC Project Grants
-
资助金额:$22.3万
-
财政年份:2004
-
负责人:A/Pr Graham Robertson
-
依托单位:
Cytochrome P450 CYP3A Regulation in Humanized Transgenic Mice
-
批准号:nhmrc : 211117
-
项目类别:NHMRC Project Grants
-
资助金额:$25.14万
-
财政年份:2002
-
负责人:A/Pr Graham Robertson
-
依托单位:
Hormonal and nutritional regulation of CYP2E1: relevance to non-alcohlic steatohepatitis
-
批准号:nhmrc : 980065
-
项目类别:NHMRC Project Grants
-
资助金额:$12.41万
-
财政年份:1998
-
负责人:A/Pr Graham Robertson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
巨噬细胞通过Piezo1感知组织硬度限制肝脏纤维化的作用机制研究
-
批准号:82371760
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:王静
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
血液蛋白参与肝细胞衰老可逆性调控机制的研究
-
批准号:32070732
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:王敏君
-
依托单位:
肝受体类似物(Liver Receptor Homolog 1, LRH 1)在雌鼠生殖过程中的作用及其机制
-
批准号:31172040
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2011
-
负责人:张丛
-
依托单位:
亚硝酸钠对肝移植物缺血再灌注损伤的保护作用及其机制
-
批准号:81170416
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:李巍
-
依托单位: